Hyperhidrosis Comorbidities and Treatments: A Register-based Study among 511 Subjects

Authors

  • Sanna-Liisa Heiskanen Faculty of Medicine, University of Oulu
  • Jani Niskala Faculty of Medicine, University of Oulu
  • Jari Jokelainen 2Northern Finland Birth Cohorts, Arctic Biobank, Infrastructure for Population Studies, Faculty of Medicine, University of Oulu, Oulu, Finland
  • Kaisa Tasanen Department of Dermatology and Medical Research Center Oulu, PEDEGO Research Unit, University of Oulu, Oulu University Hospital, Oulu, Finland
  • Laura Huilaja 3Department of Dermatology and Medical Research Center Oulu, PEDEGO Research Unit, University, of Oulu, Oulu University Hospital, Oulu, Finland
  • Suvi-Päivikki Sinikumpu 3Department of Dermatology and Medical Research Center Oulu, PEDEGO Research Unit, University, of Oulu, Oulu University Hospital, Oulu, Finland

DOI:

https://doi.org/10.2340/actadv.v102.1061

Keywords:

epidemiology, hyperhidrosis, co-morbidities

Abstract

Hyperhidrosis is a dermatological condition that causes psychosocial impairment and has a negative impact on patients’ quality of life. The epidemiology of hyperhidrosis is currently poorly understood. The aim of this study was to analyse comorbidities and treatments in 511 subjects with hyperhidrosis selected from the patient records of Oulu University Hospital. The mean age of patients with local hyperhidrosis was 27.9 years and the majority were female (62.7%). The most common anatomical site of symptoms in the youngest age group was the palms, whereas the axillae were a more common site in advanced age. Depression was a common comorbidity in both local (11.6%) and generalized hyperhidrosis (28.6%). Anxiety affected 12.7% of patients with generalized hyperhidrosis. In 36.8% of the patients with local hyperhidrosis there was a delay in diagnosis of more than 10 years. The most commonly used treatments included topical antiperspirants, iontophoresis and botulin toxin injections.

Downloads

Download data is not yet available.

References

McConaghy JR, Fosselman D. Hyperhidrosis: management options. Am Fam Physician 2018; 97: 729-734.

Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review: etiology and clinical work-up. J Am Acad Dermatol 2019; 81: 657-666.

https://doi.org/10.1016/j.jaad.2018.12.071 DOI: https://doi.org/10.1016/j.jaad.2018.12.071

Walling HW. Primary hyperhidrosis increases the risk of cutaneous infection: a case-control study of 387 patients. J Am Acad Dermatol 2009; 61: 242-246.

https://doi.org/10.1016/j.jaad.2009.02.038 DOI: https://doi.org/10.1016/j.jaad.2009.02.038

Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 2004; 51: 241-248.

https://doi.org/10.1016/j.jaad.2003.12.040 DOI: https://doi.org/10.1016/j.jaad.2003.12.040

Augustin M, Radtke MA, Herberger K, Kornek T, Heigel H, Schaefer I. Prevalence and disease burden of hyperhidrosis in the adult population. Dermatology 2013; 227: 10-13.

https://doi.org/10.1159/000351292 DOI: https://doi.org/10.1159/000351292

Eisenach JH, Atkinson JL, Fealey RD. Hyperhidrosis: evolving therapies for a well-established phenomenon. Mayo Clin Proc 2005; 80: 657-666.

https://doi.org/10.4065/80.5.657 DOI: https://doi.org/10.4065/80.5.657

Kamudoni P, Mueller B, Halford J, Schouveller A, Stacey B, Salek MS. The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation. Health Qual Life Outcomes 2017; 15: 121.

https://doi.org/10.1186/s12955-017-0693-x DOI: https://doi.org/10.1186/s12955-017-0693-x

Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res 2016; 308: 743-749.

https://doi.org/10.1007/s00403-016-1697-9 DOI: https://doi.org/10.1007/s00403-016-1697-9

Walling HW, Swick BL. Treatment options for hyperhidrosis. Am J Clin Dermatol 2011; 12: 285-295.

https://doi.org/10.2165/11587870-000000000-00000 DOI: https://doi.org/10.2165/11587870-000000000-00000

Sanclemente G, Burgos C, Nova J, Hernandez F, Gonzalez C, Reyes MI, et al. The impact of skin diseases on quality of life: a multicenter study. Actas Dermosifiliogr 2017; 108: 244-252.

https://doi.org/10.1016/j.ad.2016.11.008 DOI: https://doi.org/10.1016/j.ad.2016.11.008

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-381.

https://doi.org/10.1016/j.jbi.2008.08.010 DOI: https://doi.org/10.1016/j.jbi.2008.08.010

Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform 2019; 95: 103208.

https://doi.org/10.1016/j.jbi.2019.103208 DOI: https://doi.org/10.1016/j.jbi.2019.103208

Liu Y, Bahar R, Kalia S, Huang RY, Phillips A, Su M, et al. Hyperhidrosis prevalence and demographical characteristics in dermatology outpatients in Shanghai and Vancouver. PloS One 2016; 11: e0153719.

https://doi.org/10.1371/journal.pone.0153719 DOI: https://doi.org/10.1371/journal.pone.0153719

Shayesteh A, Janlert U, Brulin C, Boman J, Nylander E. Prevalence and characteristics of hyperhidrosis in sweden: a cross-sectional study in the general population. Dermatology 2016; 232: 586-591.

https://doi.org/10.1159/000448032 DOI: https://doi.org/10.1159/000448032

Estevan FA, Wolosker MB, Wolosker N, Puech-Leao P. Epidemiologic analysis of prevalence of the hyperhidrosis. An Bras Dermatol 2017; 92: 630-634.

https://doi.org/10.1590/abd1806-4841.20175551 DOI: https://doi.org/10.1590/abd1806-4841.20175551

Astman N, Friedberg I, Wikstrom JD, Derazne E, Pinhas-Hamiel O, Afek A, et al. The association between obesity and hyperhidrosis: a nationwide, cross-sectional study of 2.77 million Israeli adolescents. J Am Acad Dermatol 2019; 81: 624-627.

https://doi.org/10.1016/j.jaad.2019.01.019 DOI: https://doi.org/10.1016/j.jaad.2019.01.019

Kristensen JK, Moller S, Vestergaard DG, Horsten HH, Swartling C, Bygum A. Anxiety and depression in primary hyperhidrosis: an observational study of 95 consecutive Swedish outpatients. Acta Derm Venereol 2020; 100: adv00240.

https://doi.org/10.2340/00015555-3598

Kristensen JK, Vestergaard DG, Swartling C, Bygum A. Association of primary hyperhidrosis with depression and anxiety: a systematic review. Acta Derm Venereol 2020; 100: adv00044.

https://doi.org/10.2340/00015555-3598 DOI: https://doi.org/10.2340/00015555-3598

Gross KM, Schote AB, Schneider KK, Schulz A, Meyer J. Elevated social stress levels and depressive symptoms in primary hyperhidrosis. PLoS One 2014; 9: e92412.

https://doi.org/10.1371/journal.pone.0092412 DOI: https://doi.org/10.1371/journal.pone.0092412

Bahar R, Zhou P, Liu Y, Huang Y, Phillips A, Lee TK, et al. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH). J Am Acad Dermatol 2016; 75: 1126-1133.

https://doi.org/10.1016/j.jaad.2016.07.001 DOI: https://doi.org/10.1016/j.jaad.2016.07.001

Markkula N, Suvisaari J, Saarni SI, Pirkola S, Pena S, Saarni S, et al. Prevalence and correlates of major depressive disorder and dysthymia in an eleven-year follow-up - results from the Finnish Health 2011 Survey. J Affect Disord 2015; 173: 73-80.

https://doi.org/10.1016/j.jad.2014.10.015 DOI: https://doi.org/10.1016/j.jad.2014.10.015

OECD EU (2018). Health at a glance: Europe 2018: State of Health in the EU Cycle, OECD Publishing, Paris; 2018.

Korolainen MA, Kurki S, Lassenius MI, Toppila I, Costa-Scharplatz M, Purmonen T, et al. Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care. J Headache Pain 2019; 20: 13-15.

https://doi.org/10.1186/s10194-019-0964-5 DOI: https://doi.org/10.1186/s10194-019-0964-5

Thyssen JP, Johansen JD, Linneberg A, Menné T. The epidemiology of hand eczema in the general population-prevalence and main findings. Contact Derm 2010; 62: 75-87.

https://doi.org/10.1111/j.1600-0536.2009.01669.x DOI: https://doi.org/10.1111/j.1600-0536.2009.01669.x

Vartiainen E, Petays T, Haahtela T, Jousilahti P, Pekkanen J. Allergic diseases, skin prick test responses, and IgE levels in North Karelia, Finland, and the Republic of Karelia, Russia. J Allergy Clin Immunol 2002; 109: 643-648.

https://doi.org/10.1067/mai.2002.123307 DOI: https://doi.org/10.1067/mai.2002.123307

Published

2022-02-28

How to Cite

Heiskanen, S.-L., Niskala, J., Jokelainen, J., Tasanen, K., Huilaja, L., & Sinikumpu, S.-P. (2022). Hyperhidrosis Comorbidities and Treatments: A Register-based Study among 511 Subjects. Acta Dermato-Venereologica, 102, adv00656. https://doi.org/10.2340/actadv.v102.1061

Issue

Section

Articles

Categories